Official SEC submissions

Theravance Biopharma SEC Filings

Theravance Biopharma (TBPH) SEC filings, periodic reports and insider submissio…

Direct answer

Theravance Biopharma's latest SEC filing is DEFA14A.

It was filed on August 25, 2026, and 40 recent filings are available.
Each row links directly to the SEC document and filing index.

Get free Theravance Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

DEFA14A

Proxy statement

Filed:

DEFA14A

8-K

Current report

Filed:

Report date:

FORM 8-K

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

10-Q

Periodic report

Filed:

Report date:

10-Q

8-K

Current report

Filed:

Report date:

FORM 8-K

4

Insider transaction

Filed:

Report date:

PRIMARY DOCUMENT

4

Insider transaction

Filed:

Report date:

PRIMARY DOCUMENT

DEFA14A

Proxy statement

Filed:

DEFA14A

8-K

Current report

Filed:

Report date:

FORM 8-K

4

Insider transaction

Filed:

Report date:

8-K

Current report

Filed:

Report date:

FORM 8-K

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

144

Planned securities sale

Filed:

8-K

Current report

Filed:

Report date:

FORM 8-K

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

10-Q

Periodic report

Filed:

Report date:

10-Q

8-K

Current report

Filed:

Report date:

FORM 8-K

DEF 14A

Proxy statement

Filed:

Report date:

DEF 14A

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

8-K

Current report

Filed:

Report date:

FORM 8-K

10-K

Periodic report

Filed:

Report date:

10-K

8-K

Current report

Filed:

Report date:

FORM 8-K

4

Insider transaction

Filed:

Report date:

144

Planned securities sale

Filed:

Verified data

Recent filing categories
5
Recent filings
40
SEC CIK
0001583107
Latest filing date
August 25, 2026